| 加入桌面 | 手机版 | 无图版
高级搜索 标王直达
排名推广
排名推广
发布信息
发布信息
会员中心
会员中心
 
当前位置: 首页 » 招商 » 原材料 »
点击图片查看原图

18046972381;Zolpidem思诺思酒石酸唑吡坦片

  • 发布日期:2019-11-15
  • 有效期至:长期有效
TeL:180.4697.2381;N-甲酸叔丁基酯去甲基愷他命k他命,羟亚胺,氯胺酮,溴代苯丙酮,氯代苯丙酮,氰基苯丙酮,1苯基-12丙酮,,硝甲西泮,尼美西冸,咖啡因,麻黄素,麻黄碱,甲卡西酮,长治筋,甲基苯丙胺,麻古,麻果;JWH-018;AM-2201;2FDCK;2F-DCK;U-47700,U-48800,U-49900,4-ANPP,6-APB;Fentanyl;C17H22CINO3;NKET;185913-79-5.SR-121463A,C17H22ClNO3,25394-33-6,1451-82-7,chloroephedrine,8063-14-7,AMB-FUBINACA,ADB-FUBINACA,FUB-ADB,5F-ADB;Amphetamine,990-73-8,Fentanylcitrate,18063-14-7,Cannabis,FU-F,101345-66-8,Furanylfentanyl,4-FIBF,Fentanyl,Ephedrine,299-42-3;25394-33-6;2114-00-3;90717-16-1,Hydroxylimine,6740-85-8,Ketamine,6740-88-1,33795-24-3,1867-66-9,2011-67-8,Nimetazepam,Erimin5,红5,ADB;2FDCK;2F-DCK;RohypnolDarkene蓝精灵cas:1622-62-4,Flunitrazepam,Alprazolam,K2娜塔莎,K3干花,Methcathinone;Mephedrone,Ethylone,4-cmc,4-MMC,α-PVP,MDPV,罗眠乐,大蔴素,Fentanyl;Norketamine HCl,79499-59-5;1073254-49-5;35211-10-0;77-10-1;NENK;N-Ethylnorketamine;MDMA,MDA,MAM;DL-MEH;4-MEC;4-MMH;4-MMC;MDPV;α-PVP,4-cmc;安非拉酮,蓝胖子,泰勒宁氨酚羟考酮,奥施康定,芬特明,芬氟拉明,安德力减肥丸思诺思酒石酸唑吡坦片,佐匹克隆片,异丙酚丙泊酚,2-溴-4'-甲基苯丙酮

CAS: 99294-93-6
English name: ZolpidemTartrateTablets
Drug Name: Zolpidem Tartrate Tablets
Drug nickname: Sinos
Chemical name: bis[N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-]pyridin-3-yl]-acetamide] (2R , 3R)-2,3-dihydroxysuccinate.
Alias: N, N, 6-Trimethyl-2-p-tolyl-imidazo(1,2-a)pyridine-3-acetamide L-(+)-tartrate (2:1)
Molecular formula : (C19H21N3O2)2·C4H6O6
Molecular weight: 765
Indications: 1, incidental insomnia. 2. Temporary insomnia.
Dosage: 1, oral administration; 2, dose: (1) the general population: the application of this product should generally use the minimum effective dose, not more than 10mg; (2) adult dose: 10mg / day. This product should be taken before going to bed or after going to bed. Take only once a night, not multiple times; (3) Elderly: elderly patients or frail patients are particularly sensitive to zolpidem; the dose should be reduced to 5mg. The daily dose should not exceed 10mg; (4) Children: This product should not be used in patients under the age of 18 due to lack of corresponding clinical research data; (5) Impaired liver function: because of the clearance of zolpidem in patients with liver injury And metabolism is reduced, so these patients should start with the 5mg dose, especially should be used with caution in elderly patients. In adults (under 65 years of age), the dose can be increased to 10 mg only if the clinical efficacy is inadequate and the drug is well tolerated; (6) depending on the patient's symptoms, the product can be used continuously or on demand; Duration of treatment: The treatment time of this product should be as short as possible, the shortest is several days, the longest is no more than 4 weeks, including the gradual reduction period. It is not recommended to use Zolpidem for a long time. 4. Patients should be recommended to receive treatment according to the following methods. (1) for occasional insomnia (eg during travel), for 2-5 days; (2) for temporary insomnia (eg during troubles), for 2-3 weeks; (3) for patients with very short-term treatment without gradual stopping (4) Some patients may take more than 4 weeks to take the drug, but must first carefully and carefully evaluate the patient's condition before making a decision;
Properties: film-coated tablets, which are white or off-white after removal of the coating.
Packing: aluminum plastic packaging, 7 pieces / box, 20 pieces / box, 21 pieces / box.
Validity: 48 months.
Specification: 5mg, 10mg;

+θθ:293-225-3582

Dedication:
TeL: 180.4697.2381;
185913-79-5→SR-121463A, C17H22ClNO3;
C17H22CINO3;
1715016-76-4→AMB-FUBINACA;
1445583-51-6→ADB-FUBINACA,FUB-ADB;
1715016-75-3→5F-ADB; 5F-MDMB-PINACA;
C17h22cino3;
209414-07-3→FUB-JWH-018;
335161-24-5→AM-2201;
1354631-24-5→MAM-2201;
1715016-78-6→MDMB-CHMICA;
1715016-77-5→MDMB-FUBINACA;
90717-16-1→Hydroxylimine;
6740-88-1→Ketamine;
1867-66-9→Ketaject;
6740-85-8→0-Chlorphenyl Cyclopentyl Ketone;
299-42-3→Ephedrine;
33817-09-3→Methamphetamine→MDMA;
2114-00-3→2-Bromopropiophenone;
1451-82-7→Propiophenone;1-Propanone;
103-79-7→Phenylacetone;
4468-48-8→120065-76-1;
5650-44-2→Methcathinone, Mephedrone, MDPV, Ethylone, 4-cmc, α-PVP, 4-MMC;
58-08-2→Caffeine;
2011-67-8→Nimetazepam, Erimin5;
1622-62-4→Flunitrazepam, FM2, Rohypnol, Darkene, Roofies, R-2;
82-58-6→LSD;

Finished raw materials:
TeL: 180.4697.2381;
340-56-7→Metolazone;
1445583-48-1→5F-ADBICA;
1445583-51-6→FUB-ADB;
111982-50-4→2F-DCK; 2FDCK; 2-FDCK
4631-27-0→DCK;
286834-84-2→6-APB;
N9→U-47700, U-48800, U-49900, U-77891;
JWH-073, HU-210;
21409-26-7→4-ANPP;
25394-33-6→β-Chloro-N;
7726-95-6→Bromine;
1445569-01-6→4,4'-DMAR,4,4'-Dimethylaminorex;
25188-98-1→PMMA
41537-67-1→MT-45, IC-6;
93-55-0→Propiophenone;
69610-10-2, Ecstasy;
1445583-20-9→AB-PINACA;
28911-01-5→Triazolam;
591-81-1→GHB, Butanoic acid, 4-hydroxy;
56-12-2→GABA,4-Aminobutanoic acid;
25394-33-6→chloroephedrine;
8063-14-7→CANNABIS, MARIHUAA, INDIANHEMP, MARIJUANA;
101345-66-8→Furanylfentanyl, 4-FIBF, FU-F;
1350768-28-3→3-FPM, MM-FUB, PAL-593;
990-73-8→Fentanyl;
8063-14-7→Cannabis Marijuana;
94421-68-8→Anandamide;Cannabinoids;
1400742-18-8→SGT67, SGT-67, 5F-CUMYL-PICA;
106266-06-2→Risperidone;
1354631-33-6→4F-MPH, 4-mph, 4-Fluoromethylphenidate;
82003-75-6→Acrylfentanyl;

good quality:
TeL: 180.4697.2381;
122882-90-0→Valerylfentanyl;
22331-70-0→4-methoxymethamphetamine, 4-Methoxy-N, Brn 2832125;
3398-68-3→p-methoxy-N, PMMA, 4-MethoxyMethamphetamineHydrochloride;
36421-15-5→1-Butanamine, NSC51133, Einecs253-027-7;
Catha edulis Forssk;
79499-59-5→Norketamine HCl;
1073254-49-5→KetaMine-D3 hydrochloride;
90717-17-2→Methanone;
6740-87-0→N-Methyl;
35211-10-0→Norketamine; Cyclohexanone;
77-10-1→phencycliding;
1354634-10-8→NENK;
185913-78-4→SR121463;
33795-24-3→Dehydronorketamine;
33817-09-3→Amphetamine; Methamphetamine;
3789-59-1→Amino-1-phenylpropane;
69610-10-2→ecstasy, MDMA, MDA, AM, MAM;
64057-70-1→ecstasy;
208987-48-8→JWH-073;
HU-210→CP47497→JWH-307→JWH-019→JWH-250→JWH-210;
JWH-203→RCS-4, SR-19→JWH-122→THC→CANNABIDIOL;
JWH-200→MDMB-FUBINACA→MDMB-CHMICA→AMB-FUBINACA;
5F-MDMB-2201→ADB-FUBINACA→NM-2201;
94421-68-8→Anandamide;
1400742-18-8→SGT67; SGT-67; 5F-CUMYL-PICA;
1715016-78-6→MDMB-CHMICA;
1199943-44-6→UR144;CS-172;
5F-UR144→5-fluoro→5-F-UR144;
1782099-36-8→XLR11;
1971007-92-7→MMB-FUBINACA;
CP-59540;
106685-41-0→DL-MEH;
4-MEC→4-MMH→4-MMC;
24622-62-6→MDPV, MDPK;
351-03-1→4-FMA;
14530-33-7→α-PVP, Α-PVP;
5537-19-9→4-MeO-a-PVP;
5485-65-4→a-PVP, 4C-PVP, M-PVP, 9FPVP;
101345-66-8→Furanylfentanyl;
3258-84-2→Acetylfentanyl;
1169-70-6→Butyrylfentanyl;
1474-34-6→β-Hydroxythiofentanyl;
244195-31-1→4-Fluorobutyrfentanyl;
119618-70-1→Isobutyrfentanyl;
101343-69-5→Ocfentanyl;
244195-32-2→4-FIBF;

Three bags of quality:
TeL: 180.4697.2381;
2142571-01-3→THF-F;
990-73-8,→Fentanyl citrate;
437-38-7→FENTANYL;
59708-52-0→Carfentanil;
82003-75-6→Acrylfentanyl;
122882-90-0→Valerylfentanyl;
1191-85-1→ETA, ETYA, Ro 3-1428;
88441-14-9→2C-C;
1026511-90-9→2C-B;
71539-34-9→2C-E;
335161-03-0→AM694;
5470-06-4→PB-22;
96332-84-2→1-Phenyl-2-aminopropane;Benzeneethanamine;
51753-57-2→Phenazepam;
1622-61-3→Clonazepam;
846-49-1→Lorazepam;
85365-05-5→1RS, 2RS;
74698-47-8→LSD;
4764-17-4→MDA;
110925-64-9→Chloroephedrine HCL;
1112937-64-0→Ethylone;
51753-57-2→Phenazepam;
1622-61-3→Clonazepam;
846-49-1→Lorazepam;
67-66-3→Chloroform;
7726-95-6;
108-88-3→Toluene;
67-64-1→Acetone;
1354631-33-6→4F-MPH, 4-mph;
22331-70-0→4-methoxymethamphetamine;
3398-68-3→PMMA, p-methoxy-N;
36421-15-5→1-Butanamine, NSC51133;
17762-90-2→Bk-MBDB, Butylone;

Shop around:
TeL: 180.4697.2381;
1354631-24-5→MAM-2201;
1926987-29-2; 1926987-78-1; 1260840-04-7; 1260885-80-0; 1438393-11-3;
1260805-91-1; 884512-09-8;
Norketamine HCl; NKET;
79499-59-5; 83777-64-483777-65-5; 57683-62-2; 83777-70-2; 81395-70-2;
35211-10-0;100477-72-3;
THJ-018; THJ-2201; 5F-MDMB; EG-018;
1354631-77-8, 5-MAPB; 5-MAPB HCL;
1823925-53-6 5-MAPB(hydrochloride);
1354631-79-0; 6-MAPB;
1364933-55-0, 5-MAPB;
5-APB, 4-APB;
5-methoxy-N,N-diisopropyltryptamine
4021-34-5; 5-MeO-DIPT; Tryptamine;
25394-24-5, C10H14NCI•HCI;
30572-91-9;
14838-15-4, Norpseudoephedrine, Phenylpropanolamine, PPA;
111982-49-1;
1073254-49-5;
90717-17-2;
6740-87-0;
77-10-1;
1354634-10-8;
185913-78-4;
1246816-68-1;
111982-49-1;
952154-79-9, esketamine;
33643-46-8;
100001-00-1, 1P-LSD;
16066-84-5;
 
 
[ 招商搜索 ]  [ ]  [ 告诉好友 ]  [ 打印本文 ]  [ 关闭窗口 ]

留言咨询

 
联系方式
  • 联系人曹东生(先生) 经理     
  • 会员 [当前离线] [加为商友] [发送信件]
  • 电话
  • 手机
  • 地区广东-东莞市
  • 地址东莞市桥头镇桥新工业区
 
该企业最新招商